Eric Groen
General Counsel, Corporate Secretary, Chief Compliance Officer & Head of Business DevelopmentMr. Eric Groen, J.D., is General Counsel, Corporate Secretary, Chief Compliance Officer & Head of Business Development of Genelux Corporation from July 1, 2025. He was General Counsel of Rani Therapeutics Holdings, Inc. from July 2021 to May 2025. He has legal experience in corporate and private practice, including years in the healthcare industry. Prior to joining Rani, he served in various US and international roles of increasing responsibility for years at Amgen, including leading the legal teams responsible for Amgen’s business development transactions (including M&A, licensing and collaborations), operations/manufacturing, clinical trials and procurement. Most recently, He served as regional General Counsel to Amgen’s commercial business in Canada, Latin America, Middle East and Africa. He began his career in private practice at the law firm of TroyGould, where he practiced in the areas of corporate finance, securities compliance, corporate governance and mergers and acquisitions. He holds a J.D. from Harvard Law School and a B.A. in Political Science from University of California, Santa Barbara.
Positions
- Company NameGenelux CorporationStock CodeGNLXPositionGeneral Counsel, Corporate Secretary, Chief Compliance Officer & Head of Business DevelopmentColleagues
- TDThomas D. ZindrickChairman, CEO & President
- MPMatthew PulisicCFO and Principal Financial & Accounting Officer
- JCJoseph CappelloChief Technical Officer
- YYYong YuChief Scientific Officer
- JTJohn ThomasNon-Employee Independent Director
- MMMary MirabelliNon-Employee Independent Director
- JWJohn W. SmitherIndependent Director
- JLJames Lee TyreeLead Independent Director
